Radioembolization: Clinical Results Hepatocellular Carcinoma
Radioembolization is a transarterial therapy which delivers locoregional tumoricidal radiation doses to liver tumors. In this chapter, we present an overview of the available clinical data for this treatment option which is establishing its role in the management of liver tumors. Prospective analyses are needed to ascertain the benefit of radioembolization over other available therapies.
KeywordsOrthotopic Liver Transplantation Portal Vein Thrombosis Intrahepatic Cholangiocarcinoma Milan Criterion Locoregional Therapy
- Carr BI, Kondragunta V, Buch SC, Branch RA (2010) Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a Two-Cohort Study. Cancer 116(5):1305–1314Google Scholar
- Inarrairaegui M, Martinez-Cuesta A, Rodriguez M, et al (2010) Analysis of prognostic factors after Yttrium-90 Radioembolization of advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 77(5):1441–1448Google Scholar
- Kooby DA, Egnatashvili V, Srinivasan S et al (2009) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21(2):224–230Google Scholar